Indian Pharmaceutical Company Opens a R&D Center for Inhalation Products in the US

by Reshma Anand on  August 8, 2015 at 12:53 PM Corporate News
RSS Email Print This Page Comment
Lupin, a pharmaceutical company has opened a research and development center for inhalation products in Florida, the US.
Indian Pharmaceutical Company Opens a R&D Center for Inhalation Products in the US
Indian Pharmaceutical Company Opens a R&D Center for Inhalation Products in the US

The facility at Coral Springs, Florida, will focus on the research and development of inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.

"With the talent and resources this state provides, our Coral Springs expansion will further strengthen our ability to bring quality, affordable pharmaceuticals to patients in the United States and other key markets globally," said Vinita Gupta, Lupin CEO.

Source: PTI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Amyotrophic Lateral Sclerosis (ALS) 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive